Advanced Search
  • Users Online: 226
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Archives Submit article Instructions Referee Resource Subscribe
IFS PAGES
Year : 2020  |  Volume : 7  |  Issue : 1  |  Page : 125-131

Joint IFS-ISAR-ACE Recommendations on Resuming/Opening up Assisted Reproductive Technology Services

Sudha Prasad1, Prakash Trivedi2, Neena Malhotra3, Madhuri Patil4, Dakshinamoorthy Swaminathan5, Sanjay Shukla6, Kedar Ganla7
1 President, Indian fertility Society; Director, Matritava − Advanced IVF and Training Center, Delhi, India
2 President, Indian Society for Assisted Reproduction; Director, Dr. Trivedi’s Total Health Care Hospital & Aakar IVF-ICSI Centre, Mumbai India; Gynae Laparoscopist, Urogynecologist & ART Consultant Fortis Hospital, Mulund, Mumbai, India
3 Secretary, Indian fertility Society; Professor, Consultant, ART Centre, Department of All India Institute of Medical Sciences, New Delhi, India
4 Editor in Chief, Journal of Human Reproductive Sciences; Clinical Director, Dr Patil’s Fertility and Endoscopy Clinic, Bangalore, India
5 President, Academy of Clinical Embryologists, INDIA [ACE]; Scientific Director; Santhathi Centre For Reproductive Medicine, Mangalore, India
6 Secretary, Academy of Clinical Embryologists; Lab Director, Baheti Hospital & Centre for Reproductive Healthcare, Jaipur, India
7 Secretary, Indian Society for Assisted Reproduction, Fertility Consultant, Ankur Fertility Clinic, Mumbai, India

Correspondence Address:
Prof. Neena Malhotra
E-9 Ansari Nagar, AIIMS Campus, New Delhi-110 029
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/fsr.fsr_34_20

Rights and Permissions

COVID-19–A Global challenge on a scale not previously seen. Reproductive care is essential for the well-being of society and therefore the treatment needs to be completely re-thought and individualised . Infectivity and mortality rates are higher than previous pandemics and the disease is present in almost every country. Propagation and containment have varied widely by location and, at present, the timeline to complete resolution is unknown. With successful mitigation strategies in some areas and emergence of additional data, the societies have sanctioned gradual and judicious resumption of delivery of full reproductive care. When we resume, monitor local conditions, including prevalence of disease, status of government or state regulations, and availability of resource. It is important to implement proactive risk assessment within their practices prior to restarting services. One needs to develop clear and modified plans to ensure the ability to provide care while maximizing the safety of their patients and staff. One should also remain informed and stay current regarding new medical findings. These recommendations provide resources for restarting ART practice again.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed431    
    Printed35    
    Emailed0    
    PDF Downloaded57    
    Comments [Add]    

Recommend this journal

 

Sitemap | What's New | Feedback | Disclaimer
© Fertility Science and Research | Published by Wolters Kluwer - Medknow
Online since 30th Oct, 2014